[30-415-am] Cancer

Sat. Mar 30, 2024 8:30 AM - 9:30 AM [Room 415] Conference Center 415 (4F)

Chair: Kei-ichi Ozaki, Hiroko Ikeda

+Add all to schedule

8:30 AM - 8:42 AM

[30-415-am01S] Notch1 affects antiproliferative mechanisms of γ-glutamylcyclotransferase knockdown in glioblastoma stem cells

○Kozue Nose¹, Chiami Moyama¹, Masaya Mori¹, Mizuki Ishita¹, Junna Kobayashi¹, Hiromi Ii¹, Mitsugu Fujita², Susumu Nakata¹ (1. Lab. of Clinical Oncology, Kyoto Pharmaceutical Univ., 2. Faculty of Med, Kindai Univ.)

8:42 AM - 8:54 AM

[30-415-am02S] Antitumor effects on malignant pleural mesothelioma by targeting POLD1 identified using public databases

○Daiki Shimizu¹, Miku Ishibashi¹, Yuki Toda¹, Shigekuni Hosogi¹, Eishi Ashihara¹ (1. Laboratory of Clinical and Translational Physiology, Kyoto Pharmaceutical University)

8:54 AM - 9:06 AM

[30-415-am03S] Development of a novel cancer immunotherapy based on tumor immunogenicity improvement by carbamazepine and HLA-B*15:02 interaction

○Shiyori SHUN^1,2, Takeshi Susukida¹, Tomohiro Shirayanagi³, Shigeki Aoki³, Kousei Ito³, Yoshihiro Hayakawa¹ (1. Institute of Natural Medicine, Univ of Toyama, 2. Grad School of Pharm Sci, Univ of Tokyo, 3. Grad School of Pharm Sci, Chiba Univ)

9:06 AM - 9:18 AM

[30-415-am04S] Molecular mechanisms of 5-fluorouracil resistance through regulation of 5-FU metabolic activation pathway in human colorectal cancer cells

○Koichiro Nakayama¹, Nana Nishizawa¹, Chinatsu Kurasaka¹, Akira Sato¹ (1. Dept. Biochem., Fac. Pharm. Sci., Tokyo Univ. Sci.)

9:18 AM - 9:30 AM

[30-415-am05S] Effect of TNFR2 on immunosuppressive cells in tumor-bearing mice.

○Yuta TSUJI¹, Masaki INOUE^1,2, Shin-ichi TSUNODA^1,2 (1. Fac. Pharm. Sci., Kobe Gakuin Univ., 2. NIBIOHN)

Session information